Immediate Impact

1 from Science/Nature 56 standout
Sub-graph 1 of 24

Citing Papers

Allogeneic CD33-directed CAR-NKT cells for the treatment of bone marrow-resident myeloid malignancies
2025 Standout
Targeted protein degradation: from mechanisms to clinic
2024 Standout
2 intermediate papers

Works of Sara Burcheri being referenced

Efficacy and safety of lenalidomide in intermediate-2 or high-risk myelodysplastic syndromes with 5q deletion: results of a phase 2 study
2008

Author Peers

Author Last Decade Papers Cites
Sara Burcheri 242 215 332 15 587
A. Berrebi 148 189 282 22 717
Manuela Giachelia 300 255 149 21 707
Tawfiq Henni 319 188 268 26 670
A. M. Liberati 352 125 464 19 670
JP Le Couedic 252 156 289 9 590
Karin Fahl Wader 231 256 162 20 580
Caterina Fusco 304 159 150 22 610
Gutterman Ju 124 204 301 25 720
Elaine Murray 183 193 149 11 686
A Ferrant 101 169 186 27 611

All Works

Loading papers...

Rankless by CCL
2026